FDA Approved: LEVETIRACETAM — Supplemental Application (Apotex Corp.)

View source ↗

Summary

The FDA approved Apotex Corp.'s supplemental application for a generic version of levetiracetam, enabling its sale as a generic antiepileptic drug.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• LEVETIRACETAM (levetiracetam)

Snippet

SUPPL AP for LEVETIRACETAM (LEVETIRACETAM)